Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning (Q36548358)

14 August 2017

1 reference

title

Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning (English)

1 reference

14 August 2017

F Baron

1

1 reference

14 August 2017

B M Sandmaier

series ordinal

2

1 reference

14 August 2017

publication date

27 July 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

20

1 reference

14 August 2017

issue

10

1 reference

14 August 2017

page(s)

1690-1700

1 reference

How and when should we monitor chimerism after allogeneic stem cell transplantation?

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Nonmyeloablative allogeneic immunotherapy for solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

The role of reduced intensity conditioning allogeneic stem cell transplantation in patients with acute myeloid leukemia: a donor vs no donor comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age >55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Low-intensity allogeneic hematopoietic stem cell transplantation for myeloid malignancies: separating graft-versus-leukemia effects from graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Diagnostic chimerism analysis after allogeneic stem cell transplantation: new methods and markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Evaluation of STR informativity for chimerism testing--comparative analysis of 27 STR systems in 203 matched related donor recipient pairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Mixed chimerism: preclinical studies and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Assessing hematopoietic chimerism after allogeneic stem cell transplantation by multiplexed SNP genotyping using microarrays and quantitative analysis of SNP alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Evaluation and automation of hematopoietic chimerism analysis based on real-time quantitative polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Allogeneic hematopoietic cell transplantation for metastatic renal cell carcinoma after nonmyeloablative conditioning: toxicity, clinical response, and immunological response to minor histocompatibility antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body irradiation and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Graft-versus-host disease: how to translate new insights into new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective s

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-fr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Donor lymphocyte infusions after reduced intensity conditioning allogeneic transplantation: what we need to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

BCR-ABL transcripts are early predictors for hematological relapse in chronic myeloid leukemia after hematopoietic cell transplantation with reduced intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Evidence for ineffective erythropoiesis in severe sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

The fate of human Langerhans cells in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

Endogenous stem cell repopulation resulting in mixed hematopoietic chimerism following total body irradiation and marrow transplantation for acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Dose intensity and the toxicity and efficacy of allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Comparison of short tandem repeat and variable number tandem repeat genetic markers for quantitative determination of allogeneic bone marrow transplant engraftment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

High IGFBP-3 levels in marrow plasma in early-stage MDS: effects on apoptosis and hemopoiesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Inflammatory cytokines and acute graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Lessened severe graft-versus-host after "minitransplantations"

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Purified donor NK-lymphocyte infusion to consolidate engraftment after haploidentical stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Flow cytometric "rare event analysis": a standardized approach to the analysis of donor cell chimerism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404335

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404335

1 reference

release_3ehp7roedzcojankljqq3smni4

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3ehp7roedzcojankljqq3smni4

24 November 2022

mapped directly with Wikidata item

1 reference